CRIS Current Research Information System

CHIARINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.477
EU - Europa 1.993
AS - Asia 1.957
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 120
SA - Sud America 118
OC - Oceania 4
Totale 6.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.433
IT - Italia 638
SG - Singapore 537
VN - Vietnam 535
CN - Cina 429
GB - Regno Unito 377
SE - Svezia 233
DE - Germania 220
HK - Hong Kong 158
IN - India 90
BR - Brasile 88
FR - Francia 86
RU - Federazione Russa 74
UA - Ucraina 66
BD - Bangladesh 61
NL - Olanda 61
IE - Irlanda 60
FI - Finlandia 43
TG - Togo 41
EE - Estonia 35
ZA - Sudafrica 34
CI - Costa d'Avorio 30
JP - Giappone 28
CA - Canada 26
CH - Svizzera 22
BG - Bulgaria 19
JO - Giordania 18
KR - Corea 16
PH - Filippine 16
SC - Seychelles 16
BE - Belgio 15
AR - Argentina 14
IQ - Iraq 12
ID - Indonesia 10
TR - Turchia 10
HR - Croazia 9
NG - Nigeria 9
PK - Pakistan 9
TH - Thailandia 8
MX - Messico 7
PL - Polonia 6
LT - Lituania 5
UZ - Uzbekistan 5
EC - Ecuador 4
GR - Grecia 4
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
ES - Italia 3
JM - Giamaica 3
PT - Portogallo 3
SA - Arabia Saudita 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
MQ - Martinica 1
MY - Malesia 1
MZ - Mozambico 1
NP - Nepal 1
PE - Perù 1
SD - Sudan 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.688
Salva come PNG Salva come JPEG
Città #
Singapore 350
Southend 316
Ashburn 275
Parma 222
Fairfield 204
Chandler 182
Santa Clara 155
Hong Kong 152
San Jose 124
Ho Chi Minh City 119
Dong Ket 111
Ann Arbor 97
Wilmington 97
Houston 96
Woodbridge 96
Bologna 92
Hanoi 92
Seattle 89
Princeton 79
Cambridge 74
Beijing 66
Dublin 60
Boardman 58
Council Bluffs 46
Lomé 41
Helsinki 38
Lauterbourg 37
Reggio Emilia 37
Nanjing 33
Jacksonville 32
Westminster 31
Abidjan 30
Padova 30
Los Angeles 29
Dallas 27
Hefei 26
New York 24
São Paulo 24
Bremen 22
Berlin 21
Redondo Beach 21
Sofia 19
Amman 18
Saint Petersburg 18
Turin 18
Shanghai 17
Bern 16
Frankfurt am Main 16
Jinan 16
Shenyang 16
Tokyo 16
Des Moines 15
Falkenstein 15
Milan 15
Brussels 14
Florence 14
Seoul 14
Guangzhou 12
Nanchang 12
San Diego 12
Toronto 12
Chicago 11
Haiphong 11
Changsha 10
Orem 10
Tianjin 10
Abeokuta 9
Da Nang 9
Medford 9
Phoenix 9
Rome 9
Washington 9
Buffalo 8
Hebei 8
Biên Hòa 7
Hangzhou 7
Redmond 7
Can Tho 6
Falls Church 6
London 6
Moscow 6
Mülheim 6
Ningbo 6
Olalla 6
Redwood City 6
The Dalles 6
Warsaw 6
Amsterdam 5
Baghdad 5
Haikou 5
Hải Dương 5
Jakarta 5
Lappeenranta 5
Mahé 5
Mountain View 5
Norwalk 5
Rimini 5
San Francisco 5
Udine 5
Verona 5
Totale 4.328
Salva come PNG Salva come JPEG
Nome #
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 636
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 294
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. 224
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 214
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 197
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 193
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 180
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 178
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 175
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 174
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 173
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 170
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. 170
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 170
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 166
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 165
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine 165
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml 158
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 158
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 156
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 153
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis 148
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 148
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells. 147
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 145
Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia. 141
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107). 140
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 140
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 138
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. 131
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm 129
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. 127
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. 125
The role played by Wnt/beta-catenin signaling pathway in acute lymphoblastic leukemia. 120
Temsirolimus, An Allosteric mTORC1 Inhibitor, Is Synergistic with Clofarabine in AML and AML Leukemia Initiating Cells 116
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) 113
The unfolded protein response: a novel therapeutic target in acute leukemias. 102
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia 96
Surface Charge Overrides Protein Corona Formation in Determining the Cytotoxicity, Cellular Uptake, and Biodistribution of Silver Nanoparticles 92
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. 90
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients 82
null 69
Totale 6.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022710 0 24 54 54 68 32 15 64 25 128 140 106
2022/2023885 79 110 45 113 67 70 32 45 152 34 87 51
2023/2024343 19 39 32 38 23 59 13 13 10 38 21 38
2024/20251.047 31 113 134 82 214 71 75 42 9 52 44 180
2025/20262.007 145 210 161 115 234 128 174 75 367 171 100 127
2026/2027108 55 53 0 0 0 0 0 0 0 0 0 0
Totale 6.808